<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Adverse Childhood Events, Mood and Anxiety Disorders, and Substance Dependence: Gene x Environment Effects and Moderated Mediation</title>
				<funder ref="#_4G7kBfz">
					<orgName type="full">unknown</orgName>
				</funder>
				<funder ref="#_RWgYsDF">
					<orgName type="full">Veterans Integrated Service Network 4 Mental Illness Research, Education and Clinical Center</orgName>
				</funder>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability  status="unknown">
					<licence/>
				</availability>
				<date type="published" when="2021-01-26">26 January 2021</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Henry</forename><surname>Kranzler</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep2">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep3">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep4">Perelman School of Medicine Ariadni</orgName>
								<orgName type="department" key="dep5">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep6">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep7">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep8">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep9">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep10">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep11">School of Medicine</orgName>
								<orgName type="institution" key="instit1">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit2">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit3">Quinnipiac University Zeal Jinwala University of Pennsylvania</orgName>
								<orgName type="institution" key="instit4">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit5">Oikonomou University of Pennsylvania</orgName>
								<orgName type="institution" key="instit6">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit7">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit8">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit9">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit10">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit11">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit12">Yale School of Medicine</orgName>
								<orgName type="institution" key="instit13">Yale University</orgName>
								<orgName type="institution" key="instit14">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit15">University of Pennsylvania</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Christal</forename><surname>Davis</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep2">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep3">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep4">Perelman School of Medicine Ariadni</orgName>
								<orgName type="department" key="dep5">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep6">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep7">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep8">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep9">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep10">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep11">School of Medicine</orgName>
								<orgName type="institution" key="instit1">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit2">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit3">Quinnipiac University Zeal Jinwala University of Pennsylvania</orgName>
								<orgName type="institution" key="instit4">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit5">Oikonomou University of Pennsylvania</orgName>
								<orgName type="institution" key="instit6">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit7">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit8">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit9">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit10">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit11">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit12">Yale School of Medicine</orgName>
								<orgName type="institution" key="instit13">Yale University</orgName>
								<orgName type="institution" key="instit14">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit15">University of Pennsylvania</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Richard</forename><surname>Feinn</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep2">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep3">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep4">Perelman School of Medicine Ariadni</orgName>
								<orgName type="department" key="dep5">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep6">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep7">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep8">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep9">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep10">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep11">School of Medicine</orgName>
								<orgName type="institution" key="instit1">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit2">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit3">Quinnipiac University Zeal Jinwala University of Pennsylvania</orgName>
								<orgName type="institution" key="instit4">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit5">Oikonomou University of Pennsylvania</orgName>
								<orgName type="institution" key="instit6">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit7">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit8">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit9">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit10">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit11">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit12">Yale School of Medicine</orgName>
								<orgName type="institution" key="instit13">Yale University</orgName>
								<orgName type="institution" key="instit14">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit15">University of Pennsylvania</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Yousef</forename><surname>Khan</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep2">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep3">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep4">Perelman School of Medicine Ariadni</orgName>
								<orgName type="department" key="dep5">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep6">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep7">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep8">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep9">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep10">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep11">School of Medicine</orgName>
								<orgName type="institution" key="instit1">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit2">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit3">Quinnipiac University Zeal Jinwala University of Pennsylvania</orgName>
								<orgName type="institution" key="instit4">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit5">Oikonomou University of Pennsylvania</orgName>
								<orgName type="institution" key="instit6">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit7">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit8">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit9">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit10">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit11">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit12">Yale School of Medicine</orgName>
								<orgName type="institution" key="instit13">Yale University</orgName>
								<orgName type="institution" key="instit14">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit15">University of Pennsylvania</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Damaris</forename><surname>Silva-Lopez</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep2">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep3">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep4">Perelman School of Medicine Ariadni</orgName>
								<orgName type="department" key="dep5">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep6">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep7">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep8">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep9">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep10">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep11">School of Medicine</orgName>
								<orgName type="institution" key="instit1">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit2">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit3">Quinnipiac University Zeal Jinwala University of Pennsylvania</orgName>
								<orgName type="institution" key="instit4">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit5">Oikonomou University of Pennsylvania</orgName>
								<orgName type="institution" key="instit6">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit7">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit8">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit9">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit10">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit11">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit12">Yale School of Medicine</orgName>
								<orgName type="institution" key="instit13">Yale University</orgName>
								<orgName type="institution" key="instit14">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit15">University of Pennsylvania</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Isabel</forename><surname>Burton</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep2">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep3">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep4">Perelman School of Medicine Ariadni</orgName>
								<orgName type="department" key="dep5">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep6">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep7">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep8">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep9">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep10">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep11">School of Medicine</orgName>
								<orgName type="institution" key="instit1">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit2">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit3">Quinnipiac University Zeal Jinwala University of Pennsylvania</orgName>
								<orgName type="institution" key="instit4">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit5">Oikonomou University of Pennsylvania</orgName>
								<orgName type="institution" key="instit6">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit7">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit8">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit9">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit10">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit11">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit12">Yale School of Medicine</orgName>
								<orgName type="institution" key="instit13">Yale University</orgName>
								<orgName type="institution" key="instit14">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit15">University of Pennsylvania</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Morgan</forename><surname>Dixon</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep2">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep3">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep4">Perelman School of Medicine Ariadni</orgName>
								<orgName type="department" key="dep5">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep6">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep7">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep8">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep9">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep10">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep11">School of Medicine</orgName>
								<orgName type="institution" key="instit1">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit2">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit3">Quinnipiac University Zeal Jinwala University of Pennsylvania</orgName>
								<orgName type="institution" key="instit4">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit5">Oikonomou University of Pennsylvania</orgName>
								<orgName type="institution" key="instit6">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit7">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit8">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit9">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit10">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit11">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit12">Yale School of Medicine</orgName>
								<orgName type="institution" key="instit13">Yale University</orgName>
								<orgName type="institution" key="instit14">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit15">University of Pennsylvania</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jackson</forename><surname>Milone</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep2">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep3">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep4">Perelman School of Medicine Ariadni</orgName>
								<orgName type="department" key="dep5">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep6">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep7">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep8">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep9">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep10">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep11">School of Medicine</orgName>
								<orgName type="institution" key="instit1">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit2">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit3">Quinnipiac University Zeal Jinwala University of Pennsylvania</orgName>
								<orgName type="institution" key="instit4">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit5">Oikonomou University of Pennsylvania</orgName>
								<orgName type="institution" key="instit6">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit7">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit8">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit9">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit10">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit11">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit12">Yale School of Medicine</orgName>
								<orgName type="institution" key="instit13">Yale University</orgName>
								<orgName type="institution" key="instit14">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit15">University of Pennsylvania</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Sarah</forename><surname>Ramirez</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep2">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep3">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep4">Perelman School of Medicine Ariadni</orgName>
								<orgName type="department" key="dep5">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep6">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep7">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep8">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep9">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep10">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep11">School of Medicine</orgName>
								<orgName type="institution" key="instit1">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit2">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit3">Quinnipiac University Zeal Jinwala University of Pennsylvania</orgName>
								<orgName type="institution" key="instit4">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit5">Oikonomou University of Pennsylvania</orgName>
								<orgName type="institution" key="instit6">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit7">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit8">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit9">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit10">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit11">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit12">Yale School of Medicine</orgName>
								<orgName type="institution" key="instit13">Yale University</orgName>
								<orgName type="institution" key="instit14">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit15">University of Pennsylvania</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Naomi</forename><surname>Shifman</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep2">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep3">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep4">Perelman School of Medicine Ariadni</orgName>
								<orgName type="department" key="dep5">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep6">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep7">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep8">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep9">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep10">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep11">School of Medicine</orgName>
								<orgName type="institution" key="instit1">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit2">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit3">Quinnipiac University Zeal Jinwala University of Pennsylvania</orgName>
								<orgName type="institution" key="instit4">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit5">Oikonomou University of Pennsylvania</orgName>
								<orgName type="institution" key="instit6">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit7">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit8">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit9">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit10">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit11">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit12">Yale School of Medicine</orgName>
								<orgName type="institution" key="instit13">Yale University</orgName>
								<orgName type="institution" key="instit14">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit15">University of Pennsylvania</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Daniel</forename><surname>Levey</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep2">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep3">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep4">Perelman School of Medicine Ariadni</orgName>
								<orgName type="department" key="dep5">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep6">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep7">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep8">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep9">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep10">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep11">School of Medicine</orgName>
								<orgName type="institution" key="instit1">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit2">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit3">Quinnipiac University Zeal Jinwala University of Pennsylvania</orgName>
								<orgName type="institution" key="instit4">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit5">Oikonomou University of Pennsylvania</orgName>
								<orgName type="institution" key="instit6">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit7">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit8">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit9">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit10">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit11">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit12">Yale School of Medicine</orgName>
								<orgName type="institution" key="instit13">Yale University</orgName>
								<orgName type="institution" key="instit14">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit15">University of Pennsylvania</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Joel</forename><surname>Gelernter</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep2">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep3">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep4">Perelman School of Medicine Ariadni</orgName>
								<orgName type="department" key="dep5">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep6">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep7">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep8">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep9">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep10">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep11">School of Medicine</orgName>
								<orgName type="institution" key="instit1">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit2">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit3">Quinnipiac University Zeal Jinwala University of Pennsylvania</orgName>
								<orgName type="institution" key="instit4">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit5">Oikonomou University of Pennsylvania</orgName>
								<orgName type="institution" key="instit6">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit7">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit8">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit9">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit10">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit11">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit12">Yale School of Medicine</orgName>
								<orgName type="institution" key="instit13">Yale University</orgName>
								<orgName type="institution" key="instit14">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit15">University of Pennsylvania</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Emily</forename><surname>Hartwell</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep2">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep3">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep4">Perelman School of Medicine Ariadni</orgName>
								<orgName type="department" key="dep5">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep6">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep7">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep8">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep9">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep10">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep11">School of Medicine</orgName>
								<orgName type="institution" key="instit1">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit2">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit3">Quinnipiac University Zeal Jinwala University of Pennsylvania</orgName>
								<orgName type="institution" key="instit4">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit5">Oikonomou University of Pennsylvania</orgName>
								<orgName type="institution" key="instit6">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit7">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit8">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit9">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit10">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit11">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit12">Yale School of Medicine</orgName>
								<orgName type="institution" key="instit13">Yale University</orgName>
								<orgName type="institution" key="instit14">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit15">University of Pennsylvania</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Rachel</forename><surname>Kember</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep2">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep3">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep4">Perelman School of Medicine Ariadni</orgName>
								<orgName type="department" key="dep5">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep6">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep7">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep8">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep9">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep10">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep11">School of Medicine</orgName>
								<orgName type="institution" key="instit1">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit2">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit3">Quinnipiac University Zeal Jinwala University of Pennsylvania</orgName>
								<orgName type="institution" key="instit4">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit5">Oikonomou University of Pennsylvania</orgName>
								<orgName type="institution" key="instit6">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit7">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit8">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit9">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit10">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit11">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit12">Yale School of Medicine</orgName>
								<orgName type="institution" key="instit13">Yale University</orgName>
								<orgName type="institution" key="instit14">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit15">University of Pennsylvania</orgName>
							</affiliation>
						</author>
						<title level="a" type="main">Adverse Childhood Events, Mood and Anxiety Disorders, and Substance Dependence: Gene x Environment Effects and Moderated Mediation</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2021-01-26">26 January 2021</date>
						</imprint>
					</monogr>
					<idno type="DOI">10.21203/rs.3.rs-3483320/v1</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.1" ident="GROBID" when="2025-10-28T22:12+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Posted Date: October 27th</term>
					<term>2023 Alkermes</term>
					<term>Dicerna</term>
					<term>Ethypharm</term>
					<term>Lundbeck</term>
					<term>Mitsubishi</term>
					<term>Otsuka</term>
					<term>and Pear Therapeutics</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Background</head><p>Adverse childhood events (ACEs) contribute to the development of mood and anxiety disorders and substance dependence. However, the extent to which these effects are direct or indirect and whether genetic risk moderates them is unclear.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods</head><p>We examined associations among ACEs, mood/anxiety disorders, and substance dependence in 12,668 individuals (44.9% female, 42.5% African American/Black, 42.1% European American/White). We generated latent variables for each phenotype and modeled direct and indirect effects of ACEs on substance dependence, mediated by mood/anxiety disorders (forward or "self-medication" model) and of ACEs on mood/anxiety disorders, mediated by substance dependence (reverse or "substance-induced" model). In a sub-sample, we also generated polygenic scores for substance dependence and mood/anxiety disorder factors, which we tested as moderators in the mediation models.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p>Although there were signi cant indirect effects in both directions, mediation by mood/anxiety disorders (forward model) was greater than by substance dependence (reverse model). Greater genetic risk for substance dependence was associated with a weaker direct effect of ACEs on substance dependence in both the African-and European-ancestry groups (i.e., gene-environment interaction) and a weaker indirect effect in European-ancestry individuals (i.e., moderated mediation).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusion</head><p>We found greater evidence that substance dependence results from self-medication of mood/anxiety disorders than that mood/anxiety disorders are substance induced. Among individuals at higher genetic risk for substance dependence who are more likely to develop a dependence diagnosis, ACEs exert less of an effect in promoting that outcome. Following exposure to ACEs, multiple pathways lead to mood/anxiety disorders and substance dependence. Speci cation of these pathways could inform individually targeted prevention and treatment approaches.</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>INTRODUCTION</head><p>Adverse childhood events (ACEs)-such as childhood sexual abuse, physical abuse, and exposure to violence or parental alcohol and/or drug abuse-have consistently been shown to contribute to the development of psychiatric disorders, including major depressive disorder (MDD), post-traumatic stress disorder (PTSD), and substance use disorders (SUDs) <ref type="bibr">1,</ref><ref type="bibr">2,</ref><ref type="bibr">3,</ref><ref type="bibr">4,</ref><ref type="bibr">5,</ref><ref type="bibr">6,</ref><ref type="bibr">7,</ref><ref type="bibr">8,</ref><ref type="bibr">9,</ref><ref type="bibr" target="#b9">10,</ref><ref type="bibr" target="#b10">11,</ref><ref type="bibr" target="#b11">12</ref> . There is a strong linear relationship between the number of ACEs individuals experience and their risk for adverse health outcomes <ref type="bibr" target="#b12">13</ref> . In a latent class analysis (LCA) of the effects of exposure to 13 different ACEs (e.g., maltreatment, household dysfunction, and community violence), after controlling for sociodemographic characteristics and common risk factors for substance use, young adults in the high/multiple ACEs class reported higher levels of alcohol-related problems, current tobacco use, and psychological symptoms than those in the low ACEs class <ref type="bibr" target="#b9">10</ref> . Similarly, in an LCA of 11,386 US older adults that yielded 4 classes of ACEs-high adversity (6%), low adversity (69%), child abuse (16%), and parental substance abuse (8%) -rates of SUDs were lower in the low-adversity group than the other three groups after controlling for demographic measures. Additionally, the high-adversity and child abuse groups were more likely to have experienced major depression than the low-adversity group. <ref type="bibr" target="#b11">12</ref> Greater insight into the nature of the relationship between ACEs and mood/anxiety and SUDs can be gained from mediation models, which can differentiate direct effects of ACEs on these disorders from indirect (i.e., mediated) ones and show the directionality of the causal effects, which can both inform theory and have clinical utility. Douglas et al. <ref type="bibr" target="#b13">14</ref> reported that a summary measure of mood and anxiety disorders (M/ADs) that preceded a substance dependence (SD) diagnosis partially mediated the effect of ACEs on SD risk.</p><p>Here, we sought to replicate those ndings in a larger sample and to compare two mediation models that differed in the hypothesized direction of effect by using information on ages of onset of the disorders to establish temporality. The forward model, consistent with the self-medication hypothesis <ref type="bibr" target="#b14">15,</ref><ref type="bibr">16,</ref><ref type="bibr" target="#b16">17</ref> , posits that M/ADs mediate the relationship between ACEs and SD diagnoses. In the reverse model, consistent with M/ADs being substance induced <ref type="bibr">18</ref> , SD mediates the relationship between ACEs and M/ADs. In view of the bidirectional relationship between M/ADs and SD described in the literature <ref type="bibr" target="#b18">19,</ref><ref type="bibr" target="#b19">20,</ref><ref type="bibr" target="#b20">21,</ref><ref type="bibr" target="#b21">22,</ref><ref type="bibr" target="#b22">23,</ref><ref type="bibr" target="#b23">24,</ref><ref type="bibr" target="#b24">25,</ref><ref type="bibr">26,</ref><ref type="bibr" target="#b26">27,</ref><ref type="bibr">28,</ref><ref type="bibr" target="#b28">29,</ref><ref type="bibr" target="#b29">30,</ref><ref type="bibr" target="#b30">31</ref> , we examined effects in both directions.</p><p>Whereas not everyone who experiences an ACE goes on to develop an M/AD or SD, genetic liability could help to explain variation in risk for these disorders <ref type="bibr" target="#b31">32</ref> . Incorporating genetic information into mediation analyses can indicate whether causal pathways in the development of SUDs and M/ADs differ for individuals at varying levels of genetic risk (i.e., whether there exists a gene x environment (GxE) interaction). Specifying the pathway from early childhood experiences to later psychiatric and substancerelated outcomes is critical for developing effective, individually targeted prevention and treatment approaches. Polygenic risk scores (PRS), calculated by summing the effects of genetic variants across the genome, can re ect an individual's aggregate genetic liability for a particular trait or disorder. The effects of PRS, if large enough, could be useful clinically <ref type="bibr" target="#b32">33,</ref><ref type="bibr" target="#b33">34,</ref><ref type="bibr" target="#b34">35</ref> . We therefore also examined PRS for M/ADs and SD as moderators of the direct and indirect effects of ACEs in both models.</p><p>We tested several hypotheses. First, we expected to replicate the ndings of Douglas et al. <ref type="bibr" target="#b13">14</ref> by showing that ACEs have both direct and indirect effects on SD risk, with the latter mediated by M/ADs. Second, we hypothesized that this mediating effect of M/ADs in the forward, self-medication model would be larger than the mediating effect of an SD diagnosis on the relationship between ACEs and the occurrence of an M/AD in the reverse, substance-induced model. Third, we hypothesized that the SD PRS would positively moderate the direct effect of ACEs on SD (i.e., that a higher SD PRS would be associated with a greater impact of ACEs on SD). Fourth, we hypothesized that the M/AD PRS would positively moderate the direct effect of ACEs on M/AD (i.e., that a higher M/AD PRS would be associated with a greater impact of ACEs on M/ADs). Finally, we hypothesized that the SD and M/AD PRS would moderate the mediating effects of M/ADs and SD, respectively, with no directional hypotheses for these effects.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>METHODS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Overview</head><p>We rst examined the subgroup of participants who had onset of an M/AD prior to the onset of an SD diagnosis (forward model consistent with a self-medication hypothesis) and then repeated the analysis among individuals whose rst SD diagnosis occurred prior to the onset of an M/AD (reverse model consistent with substance-induced mood changes). The mediation analyses combined all individuals irrespective of self-identi ed race. We used summary statistics from large genome-wide association studies (GWAS) of M/ADs ,36, <ref type="bibr" target="#b36">37,</ref><ref type="bibr">38,</ref><ref type="bibr" target="#b38">39,</ref><ref type="bibr" target="#b39">40,</ref><ref type="bibr" target="#b40">41,</ref><ref type="bibr" target="#b41">42,</ref><ref type="bibr" target="#b42">43,</ref><ref type="bibr" target="#b43">44</ref> and SUDs <ref type="bibr" target="#b44">45,</ref><ref type="bibr">46,</ref><ref type="bibr" target="#b46">47,</ref><ref type="bibr">48,</ref><ref type="bibr" target="#b48">49</ref> to derive latent genetic factors for the two traits using genomic structural equation modeling (gSEM). Using summary statistics from GWAS on the latent genetic factors, we calculated PRS in the Yale-Penn sample. We then examined the moderating effect of PRS for M/ADs on the relationship between ACEs and M/ADs and of PRS for SD on the relationship between ACEs and SD, separately by ancestral group.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Participants</head><p>We included 12,668 individuals from the Yale-Penn sample, a family-based and case-control sample that was recruited at Yale University, UConn Health, the University of Pennsylvania, the Medical University of South Carolina, and McLean Hospital for studies of the genetics of SD <ref type="bibr" target="#b49">50</ref> . The institutional review board at each site approved the study protocol. All participants received a complete description of the study, gave written informed consent, and were paid to complete the assessments and provide a blood or saliva sample for genotyping.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Assessment Procedures</head><p>The family-based sample was ascertained through two or more siblings affected with a lifetime diagnosis of cocaine and/or opioid dependence. The case-control sample comprises unrelated cases with a lifetime diagnosis of alcohol, cocaine, tobacco, cannabis, or opioid dependence, and controls who were included based on the absence of any of these diagnoses. Additional family members of probands from family-based studies and of cases from case-control studies were also recruited irrespective of their SD status. DSM-IV <ref type="bibr" target="#b50">51</ref> SD diagnoses were obtained with the Semi-Structured Assessment for Drug Dependence and Alcoholism (SSADDA), which elicits information on age of onset of a variety of psychiatric and SD diagnoses. The reliability of the SSADDA for both psychiatric and SD diagnoses and individual criteria has been reported previously <ref type="bibr" target="#b51">52,</ref><ref type="bibr" target="#b52">53</ref> . Whereas SD diagnoses in the Yale-Penn sample were based on DSM-IV, diagnoses in the GWAS discovery samples used to generate PRS were largely based on SUD diagnoses in the International Classi cation of Diseases.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Measures</head><p>Adverse Childhood Events Latent Variable. Ten variables re ected participants' experiences in before age 13. The test-retest and inter-rater reliability estimates for these items ranged from 0.62 to 0.99 and 0.41 to 0.82, respectively. All variables were dichotomized to ensure the same coding and equal weight among them. Two variables re ected the perceived instability of the participants' home life: multiple main caregivers (3 or more) and multiple family relocations (2 or more). Three variables re ected childhood traumatic experiences: violent crime, sexual abuse, and physical abuse. Violent crime was de ned as witnessing or experiencing a violent crime, like a shooting or a rape. Sexual abuse was assessed by asking whether the respondent was ever sexually abused. Physical abuse was de ned as being beaten by an adult so badly that medical care was needed or marks on the body remained for more than 30 days.</p><p>The remaining variables were household substance use, regular household smoking, and three variables thought to be potentially protective against ACEs that were reverse coded so that lower levels were less protective: frequency of religious participation (never vs. ever), quality of relationship with the main caregiver (poor vs. moderate or greater), and frequency of contact with other relatives (less than monthly vs. more frequent contact). All 10 variables loaded signi cantly onto a single ACEs latent variable, with item loadings ranging from 0.16 (for no religious involvement) to 0.71 for physical abuse (see Supplementary Fig. <ref type="figure">1</ref>).</p><p>Substance Dependence Latent Variable. The SD latent variable comprised DSM-IV SD diagnoses for alcohol, cocaine, opioids, tobacco, and cannabis. These ve diagnoses loaded well onto a single factor, with all item loadings 0.69 (see Supplementary Fig. <ref type="figure">2</ref>).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Mood and Anxiety Disorders Latent Variable. We included eight psychiatric disorders (major depressive disorder [MDD], bipolar disorder, posttraumatic stress disorder [PTSD], generalized anxiety disorder [GAD],</head><p>obsessive-compulsive disorder [OCD], social phobia, agoraphobia, and panic disorder) as indicators for a single M/AD latent variable. We included PTSD among the M/ADs because diagnoses in the target sample were made using DSM-IV, in which PTSD is categorized as an anxiety disorder. All item loadings were signi cant, ranging from 0.11 for MDD to 1.00 for PTSD (see Supplementary Fig. <ref type="figure">3</ref>).</p><p>Demographics. Seven demographic characteristics served as control variables in the mediation models: sex, age, self-identi ed race/ethnicity [African American/Black, European American/White, Hispanic/Latino, or Other (includes Native/American, Asian, Paci c Islander, and Other)], marital status (never married vs. ever married or cohabiting), years of education, employment status, and annual household gross income ($10,000, $10-29,999, $30-74,999, $75,000). Self-identi ed race/ethnicity was omitted as a control variable in the moderation analyses, which were run separately for the Africanand European-ancestry groups.</p><p> Polygenic Risk Scores. To create PRS that captured general genetic liability for M/ADs and SUDs, we used summary statistics from large genome-wide association studies (GWAS) of M/ADs (Supplementary Tables <ref type="table" target="#tab_0">1</ref> and<ref type="table" target="#tab_1">2</ref>) and SUDs (Supplementary Tables <ref type="table" target="#tab_2">3</ref> and<ref type="table" target="#tab_3">4</ref>) and genomic structural equation modeling (gSEM <ref type="bibr" target="#b53">54</ref> ) to derive latent genetic factors for African-and European-ancestry separately (Supplementary Tables 5-10 and Supplementary Figs. 4-7 provide additional details). Prior to applying gSEM, multi-trait analysis of GWAS (MTAG <ref type="bibr" target="#b54">55</ref> ) was used to jointly analyze summary statistics from three GWAS of anxietyrelated traits in European-ancestry samples <ref type="bibr">36,</ref><ref type="bibr" target="#b36">37,</ref><ref type="bibr">38</ref> to boost power to detect genetic associations related to a broad spectrum of anxiety disorders. Using GWAS of the latent genetic factors, we generated summary statistics and then calculated ancestry-speci c M/AD and SUD PRS in the Yale-Penn sample (African-ancestry n = 2,284, European-ancestry n = 2,871; details on genetic QC and ancestry assignment have been reported previously <ref type="bibr" target="#b49">50</ref> .</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Analyses</head><p>We compared demographic characteristics across SD and M/AD groups using chi-square for categorical variables and t-test for continuous variables. We also examined whether the odds of experiencing each of the ACEs differed for participants with and without SD and M/AD diagnoses using Mplus version 8.10 56 . First, latent factors were created for ACEs, SD, and M/AD. Whereas all indicators were binary variables, we used the WLSMV estimator. The factor loadings of all indicators in the correlated factors CFA were signi cant, and the overall model demonstrated good t (CFI = 0.95, RMSEA = 0.037). Next, the factor loadings were xed for the two mediation models (see Fig. <ref type="figure">1</ref>), one in which the M/AD factor was the mediator and the SD factor the outcome (i.e., the forward or self-medication model) and a second model in which the mediator was the SD factor and the M/AD factor the outcome (i.e., the reverse or substanceinduced model). In both models, the ACEs factor served as the independent variable. Age of onset for rst SD diagnosis and rst M/AD was used to select a subset of the sample for each mediation model to maintain the temporal order of mediation.</p><p>Excluding participants from the forward model if the onset of their rst SD occurred before the onset of their rst M/AD left a nal n = 4,128. Similarly, excluding participants from the reverse model if the onset of their rst M/AD occurred before the age of onset for SD left a nal n = 2,957. Participants who had the same age of onset for SD and an M/AD (n = 395) were included in both models. As a sensitivity analysis, we repeated the mediation analyses after excluding these individuals. Whereas the results were substantively unchanged, we present the ndings that include these individuals.</p><p>The mediator and outcome in both models were regressed on the demographic covariates. To account for the fact that 2% of participants belonged to the same family, we used the COMPLEX analysis option for nested data. The model INDIRECT command was used to estimate the indirect effects and the bootstrap procedure with 1,000 bootstrap samples served to generate 95% con dence intervals.</p><p>We then conducted moderated mediation analyses that included the SUD and M/AD PRS as moderators.</p><p>In the forward or self-medication models (see Fig. <ref type="figure">2</ref> Panel A), we included the M/AD PRS as a moderator of the indirect path from ACEs to M/ADs (path a), the SUD PRS as a moderator of the indirect path from M/ADs to SD (path b), and SUD PRS as a moderator of the direct path from ACEs to SD (path c'). In the reverse or substance-induced models (see Fig. <ref type="figure">2</ref> Panel B), we included the SUD PRS as a moderator of the indirect path from ACEs to SD (path a), the M/AD PRS as a moderator of the indirect path from SD to M/ADs (path b), and the M/AD PRS as a moderator of the direct path from ACEs to M/ADs (path c'). The moderated mediation analyses were limited to the subset of participants with genetic data (African ancestry, n = 2,284; European ancestry, n = 2,871) and were run separately by ancestral group.</p><p>(See Figs. <ref type="figure">1</ref> and<ref type="figure">2</ref>)</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RESULTS</head><p>As shown in Table <ref type="table" target="#tab_0">1</ref>, the Yale-Penn sample comprised 12,668 individuals, 55.1% of whom were male, with an average age of 40.7 years (SD = 12.1) and nearly equal percentages of self-identi ed African American/Black (42.5%) and European American/White (42.1%), and smaller percentages of Hispanic/Latino (7.6%) and other racial/ethnic groups (7.7%). Only 17.8% of the sample was married or cohabiting. Participants averaged 12.8 (SD = 2.4) years of education, and 57.1% were currently employed. A plurality of individuals (43%) reported an annual gross household income of less than $10,000. The most common SD diagnosis was alcohol dependence (89%) and the least common was opioid dependence (42%). The average number of SD diagnoses was 3.2 (SD = 1.3), ranging from one (12%) to ve (17%). Participants with an SD diagnosis were younger and more likely to be male and African American, have lower income and a lower education level, and less likely to be employed or married (see Table <ref type="table" target="#tab_0">1</ref>). Participants with SD were more likely to experience each of the ACEs and to lack protective factors (see Table <ref type="table" target="#tab_2">3</ref>), with the highest odds being for physical abuse (OR = 4.16), witnessing violent crime (OR = 3.91), and household substance use (OR = 3.56).</p><p>The most common M/AD diagnosis was PTSD (59.9%), with generalized anxiety disorder being least prevalent (3%). The average number of M/ADs was 1.5 (SD = 0.8), with most participants (68%) having a single diagnosis. Individuals with an M/AD diagnosis were younger and more likely to be female, European American, have a lower income, and less likely to be married or working. Individuals with an M/AD diagnosis were more likely to experience ACEs and to lack protective factors (see Table <ref type="table" target="#tab_2">3</ref>), with the largest effects being that of a poor relationship with the main caregiver (OR = 3.72), experiencing physical abuse (OR = 3.59), and experiencing sexual abuse (OR = 3.57). Non-participation in religious activities had the weakest association with both outcomes (SD: OR = 1.28, M/ADs: OR = 1.16). Note: *Refers to lack of protective factors against the harms of adverse childhood events; SD = substance dependence, OR = odds ratio. All p-values are &lt; .001 unless otherwise indicated. a p-value = .014, b p-value = .002.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Mediation Models</head><p>All paths in the forward mediation model were signi cant. There was a direct effect of ACEs on SDs ( = 0.15, SE = 0.01, p &lt; 0.001), with individuals who experienced more ACEs being more likely to develop an SD. There was also an indirect effect operating through M/ADs ( = 0.08, SE = 0.01, p &lt; 0.001; see Table <ref type="table" target="#tab_3">4</ref> and Fig. <ref type="figure">1</ref>, Panel A), which accounted for 34% (0.075/0.221) of the total effect of ACEs on SD. Note: Models included sex, age, race, marital status, years of education, employment status, and income as covariates. SE = standard error, CI = con dence interval. <ref type="bibr">1</ref> Model was restricted to participants with an age of onset of rst substance dependence diagnosis at or after their age of onset for a rst mood/anxiety disorder diagnosis. <ref type="bibr">2</ref> Model was restricted to participants with an age of onset for a rst mood/anxiety disorder at or after their age of onset for a rst substance dependence diagnosis.</p><p> All paths in the reverse model were also signi cant (see Table <ref type="table" target="#tab_3">4</ref> and Fig. <ref type="figure">1</ref>, Panel B). There was a signi cant direct effect of ACEs on M/ADs ( = 0.36, SE = 0.03, p &lt; 0.001), with individuals who experienced more ACEs being more likely to develop a M/AD. There was also a signi cant, albeit small, indirect effect operating through SDs ( = 0.04, SE = 0.01, p &lt; 0.001), which accounted for 10% (0.041/0.397) of the total effect of ACEs on M/ADs.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Genetic Moderation and Moderated Mediation</head><p>African Ancestry (AA). Among AA individuals, the direct effect of ACEs on SD was moderated by the SUD PRS ( = -0.15, p &lt; 0.001), with a smaller effect of ACEs on SD for those with a higher SUD PRS (see Table <ref type="table" target="#tab_4">5</ref> and Fig. <ref type="figure">2</ref>, Panel A). There was no evidence for moderated mediation in the forward or reverse models among AA individuals (see Table <ref type="table" target="#tab_4">5</ref> and Fig. <ref type="figure">2</ref>). European Ancestry (EA). Among EA individuals, consistent with results in AA individuals, the direct effect of ACEs on SD was moderated by the SUD PRS (= -0.21, p &lt; 0.001), where again there was a smaller effect of ACEs on SD for those with a higher SUD PRS. There was no signi cant moderated mediation in this model (see Table <ref type="table" target="#tab_4">5</ref> and Fig. <ref type="figure">2</ref>, Panel A). However, in the reverse or substance-induced model, there was evidence for moderated mediation of path a (from ACEs to SD; = -0.06, p &lt; 0.001), where again</p><formula xml:id="formula_0"> </formula><p>higher genetic risk for SUD was associated with a smaller effect of ACEs on SD risk. There was no evidence that genetic risk moderated any other paths (see Table <ref type="table" target="#tab_4">5</ref> and Fig. <ref type="figure">2</ref>, Panel B).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCUSSION</head><p>Consistent with our hypotheses, there were both direct and indirect effects of ACEs on SDs and M/ADs. In a sample more than double the size of our previous study sample, <ref type="bibr" target="#b13">14</ref> we replicated our earlier ndings that the effect of ACEs on SD risk was mediated by M/ADs. Leveraging the power of the larger sample, we extended these ndings by examining effects in the reverse model-i.e., in which the effects of ACEs on M/ADs were mediated by SD risk. Although we found both direct and indirect effects in both the forward and reverse models-underscoring the bidirectional nature of the relationship between M/AD and SD-the indirect effect in the forward model was greater than that in the reverse model, providing greater support for the self-medication hypothesis than for substance-induced mood/anxiety disorders.</p><p>The self-medication hypothesis <ref type="bibr" target="#b14">15,</ref><ref type="bibr">16,</ref><ref type="bibr" target="#b16">17</ref> , rst posited in 1997, states that psychopathology is accompanied by aversive internal states that motivate individuals to use psychoactive substances to relieve them <ref type="bibr" target="#b56">57</ref> .</p><p>Research has shown that ACEs negatively impact emotion regulation skills <ref type="bibr">58,</ref><ref type="bibr" target="#b58">59</ref> , which help individuals modulate distressing emotions in adaptive ways. These individuals may develop SDs following repeated attempts to alleviate troubling mood states and distressing emotions that result from exposure to ACEs by using substances. In contrast, the development of M/ADs following ACEs was largely due to direct effects, with mediation through SDs accounting for only 10% of the overall effect. This indirect pathway represents substance-induced M/ADs, which have been posited by some to account for a substantial amount of the comorbidity between SUDs and psychiatric disorders 60 . In this theory, M/ADs in the context of SUDs are temporary conditions that occur largely due to intoxication or withdrawal <ref type="bibr">60</ref> . In contrast to M/ADs that develop from self-medication, those that are substance-induced resolve with abstinence from substance use 61 . Although our results re ect bidirectional pathways to M/ADs among individuals who experience ACEs, we found less support for the substance-induced pathway than the selfmedication pathway. Thus, M/ADs among individuals who experienced ACEs are more likely to be a direct product of these early events.</p><p>These ndings highlight potential opportunities to improve treatment outcomes among individuals who have experienced ACEs. Results of both our forward and reverse models highlight the importance of preventing or reducing young people's exposure to ACEs as a means of decreasing the risk of both M/ADs and SDs. Improved screening efforts within healthcare and school settings 62,63 and the facilitation of community cohesion <ref type="bibr">64,</ref><ref type="bibr">65</ref> show promise in mitigating the substantial public health burden of ACEs. Although substance misuse is often seen as a more pressing problem clinically, targeting premorbid M/ADs among individuals who use substances may help to reduce the intensity of use and thereby prevent the development of an SUD, even if the underlying M/AD does not remit fully. Whereas individuals in treatment for an SUD report rates of exposure to ACEs as high as 100% 66,67,68 , providing clinical interventions that target adaptive mood regulation to this patient population could help to reduce the impact of ACEs on psychosocial functioning 69 , improve retention in SUD treatment programs <ref type="bibr" target="#b69">70</ref> , and reduce rates of relapse <ref type="bibr" target="#b70">71</ref> .</p><p>Although as hypothesized, genetic risk for SUD moderated the effects of ACEs on the development of an SD, i.e., a GxE effect, it was in a direction opposite our hypothesis. Rather than an interaction effect consistent with the diathesis-stress model <ref type="bibr" target="#b71">72</ref> , we found the association between ACEs and SDs to be lower among individuals with a higher SUD PRS. This suggests, rst, that a higher genetic liability for SUD has a greater impact on the likelihood of an SD than an environmental (ACEs) factor. Thus, exposure to ACEs contributes more to SUD risk in individuals who are not highly genetically predisposed to develop an SUD. Taken together, this provides evidence of two different mechanisms by which an individual may develop an SUD following exposure to ACEs, which depend on the magnitude of the individual's genetic liability to SUDs.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Limitations Strengths</head><p>This study has limitations. First, we chose to include PTSD in our latent M/AD factor because it is classi ed as an anxiety disorder in DSM-IV, the diagnostic system on which all psychiatric diagnoses in the Yale-Penn sample are based. This could have in ated the association between ACEs and M/ADs, because several of the ACEs (e.g., physical abuse or sexual abuse) are index traumas for PTSD. Second, there was greater heterogeneity in the M/AD latent variable than the SD latent variable, as evidenced by the lower trait loadings. This, combined with the smaller discovery GWAS for M/ADs 36, <ref type="bibr" target="#b36">37,</ref><ref type="bibr">38,</ref><ref type="bibr" target="#b38">39,</ref><ref type="bibr" target="#b39">40,</ref><ref type="bibr" target="#b40">41,</ref><ref type="bibr" target="#b41">42,</ref><ref type="bibr" target="#b42">43,</ref><ref type="bibr" target="#b43">44</ref> than for SUDs, particularly among African-ancestry individuals, <ref type="bibr" target="#b44">45,</ref><ref type="bibr">46,</ref><ref type="bibr" target="#b46">47,</ref><ref type="bibr" target="#b48">49</ref> may have contributed to the failure to detect moderated mediation effects for the M/AD PRS. Among African-ancestry individuals, the smaller discovery samples also limited statistical power of the SD latent genetic factor and PRS. Finally, although we used self-reported ages of onset to ensure the temporal precedence required for modeling mediation effects, the data were reported retrospectively, which could have introduced bias in the selection of individuals for the forward and reverse models. The sensitivity analysis in which we removed individuals who experienced their rst M/AD and SD in the same year showed no substantive effect on model outcomes. This suggests that the ndings are generally robust to errors in recall of age of onset of the disorders.</p><p>Despite these limitations, the study has key strengths, including its large discovery and target sample sizes, ability to examine mediation in two models of theoretical importance, and ndings of genetic moderation in both AA and EA individuals. The use of gSEM to leverage the considerable overlap in SUDs and M/ADs to construct ancestry-speci c latent genetic factors and then subject them to GWAS likely yielded greater statistical power than a single GWAS could provide. Such multivariate approaches could facilitate more equitable application of ndings from genetic studies by enhancing power to detect effects even when discovery GWAS are of modest size, which is often the case for samples of non-European ancestry.</p><p>Figures</p></div><figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc></figDesc><graphic coords="25,28.00,36.00,402.36,581.77" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1</head><label>1</label><figDesc>Demographic characteristics of participants with and without a substance dependence diagnosis.</figDesc><table><row><cell></cell><cell>Overall</cell><cell>Substance</cell><cell>No Substance</cell><cell>p-value Effect</cell></row><row><cell></cell><cell></cell><cell>Dependence</cell><cell>Dependence</cell><cell>Size*</cell></row><row><cell></cell><cell>N =</cell><cell></cell><cell></cell></row><row><cell></cell><cell>12,668</cell><cell>N = 9,695</cell><cell>N = 2,973</cell></row><row><cell>Sex</cell><cell></cell><cell></cell><cell></cell><cell>&lt; 0.001</cell><cell>0.578</cell></row><row><cell>Male</cell><cell>55.1%</cell><cell>61.7%</cell><cell>33.8%</cell></row><row><cell>Age</cell><cell></cell><cell></cell><cell></cell><cell>&lt; 0.001</cell><cell>0.076</cell></row><row><cell>Mean  std. dev.</cell><cell>40.7 </cell><cell>40.5  11.2</cell><cell>41.4  14.6</cell></row><row><cell></cell><cell>12.1</cell><cell></cell><cell></cell></row><row><cell>Race/Ethnicity</cell><cell></cell><cell></cell><cell></cell><cell>&lt; 0.001</cell><cell>0.127</cell></row><row><cell>African American</cell><cell>42.5%</cell><cell>43.6%</cell><cell>39.2%</cell></row><row><cell>European American</cell><cell>42.1</cell><cell>40.5</cell><cell>47.5</cell></row><row><cell>Hispanic/Latino</cell><cell>7.6</cell><cell>8.1</cell><cell>5.9</cell></row><row><cell>Other</cell><cell>7.7</cell><cell>7.8</cell><cell>7.5</cell></row><row><cell>Marital Status</cell><cell></cell><cell></cell><cell></cell><cell>&lt; 0.001</cell><cell>0.626</cell></row><row><cell>Married</cell><cell>17.8%</cell><cell>12.4%</cell><cell>35.6%</cell></row><row><cell>Education (Years)</cell><cell></cell><cell></cell><cell></cell><cell>&lt; 0.001</cell><cell>1.211</cell></row><row><cell>Mean  std. dev.</cell><cell>12.8 </cell><cell>12.2  2.2</cell><cell>14.7  2.0</cell></row><row><cell></cell><cell>2.4</cell><cell></cell><cell></cell></row><row><cell>Employment</cell><cell></cell><cell></cell><cell></cell><cell>&lt; 0.001</cell><cell>0.637</cell></row><row><cell>Employed</cell><cell>57.1%</cell><cell>48.5%</cell><cell>78.8%</cell></row><row><cell>Income</cell><cell></cell><cell></cell><cell></cell><cell>&lt; 0.001</cell><cell>1.043</cell></row><row><cell>&lt;$10,000</cell><cell>43.0%</cell><cell>51.3%</cell><cell>15.6%</cell></row><row><cell>$10,000-$29,999</cell><cell>28.2</cell><cell>29.4</cell><cell>24.2</cell></row><row><cell>$30,000-$74,999</cell><cell>20.4</cell><cell>14.9</cell><cell>39.5</cell></row><row><cell>$75,000+</cell><cell>8.4</cell><cell>4.4</cell><cell>21.6</cell></row></table><note><p><p><p><p>Note: * Standardized difference with eta-squared conversion applied to race. std. dev. = standard deviation.</p>There were 9,695 cases (76.5%) with one or more lifetime alcohol, cocaine, opioid, tobacco, or cannabis dependence diagnoses, and 2,973 SD controls (23.5%) (see Table</p>2</p>). Nearly one-third of individuals (4,205 or 33.2%) had one or more M/ADs and the remaining 8,463 participants (66.8%) had no M/AD. Nearly half (6,032 or 47.6%) of participants had only an SD diagnosis, 542 (4.3%) had only an M/AD diagnosis, 3,663 (28.9%) had both SD and M/AD diagnoses, and 2,431 (19.2%) had neither diagnosis.</p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2</head><label>2</label><figDesc>Demographic characteristics of participants with and without a mood or anxiety disorder.</figDesc><table><row><cell></cell><cell>Mood or Anxiety</cell><cell>No Mood or Anxiety</cell><cell>p-value Effect</cell></row><row><cell></cell><cell>Disorder</cell><cell>Disorder</cell><cell>Size*</cell></row><row><cell></cell><cell>N = 4,205</cell><cell>N = 8,463</cell></row><row><cell>Sex</cell><cell></cell><cell></cell><cell>&lt; 0.001</cell><cell>0.232</cell></row><row><cell>Male</cell><cell>47.5%</cell><cell>59.0%</cell></row><row><cell>Age</cell><cell></cell><cell></cell><cell>0.021</cell><cell>0.038</cell></row><row><cell>Mean  std. dev.</cell><cell>40.4  11.7</cell><cell>40.8  12.3</cell></row><row><cell>Race/Ethnicity</cell><cell></cell><cell></cell><cell>&lt; 0.001</cell><cell>0.155</cell></row><row><cell>African American</cell><cell>37.0%</cell><cell>45.3%</cell></row><row><cell>European American</cell><cell>45.5</cell><cell>40.4</cell></row><row><cell>Hispanic/Latino</cell><cell>8.7</cell><cell>7.0</cell></row><row><cell>Other</cell><cell>8.8</cell><cell>7.3</cell></row><row><cell>Marital Status</cell><cell></cell><cell></cell><cell>&lt; 0.001</cell><cell>0.128</cell></row><row><cell>Married</cell><cell>14.6%</cell><cell>19.5%</cell></row><row><cell>Education (Years)</cell><cell></cell><cell></cell><cell>&lt; 0.001</cell><cell>0.174</cell></row><row><cell>Mean  std. dev.</cell><cell>12.5  2.4</cell><cell>12.9  2.4</cell></row><row><cell>Employment</cell><cell></cell><cell></cell><cell>&lt; 0.001</cell><cell>0.093</cell></row><row><cell>Employed</cell><cell>53.9%</cell><cell>58.5%</cell></row><row><cell>Income</cell><cell></cell><cell></cell><cell>&lt; 0.001</cell><cell>0.205</cell></row><row><cell>&lt;$10,000</cell><cell>48.1%</cell><cell>40.4%</cell></row><row><cell>$10,000-$29,999</cell><cell>28.6</cell><cell>28.0</cell></row><row><cell>$30,000-$74,999</cell><cell>17.7</cell><cell>21.7</cell></row><row><cell>$75,000+</cell><cell>5.6</cell><cell>9.8</cell></row></table><note><p>Note: * Standardized difference with eta-squared conversion applied to race. std. dev. = standard deviation, MDD = major depressive disorder, Bipolar = Bipolar Disorder, PTSD = posttraumatic stress disorder, GAD = generalized anxiety disorder, OCD = obsessive compulsive disorder.</p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 3</head><label>3</label><figDesc>Prevalence rates and odds of adverse childhood events across substance dependence and mood and anxiety disorder groups.</figDesc><table><row><cell></cell><cell>Substance</cell><cell>No Substance</cell><cell>OR</cell><cell>Mood/</cell><cell>No</cell><cell>OR</cell></row><row><cell></cell><cell>Dependence</cell><cell>Dependence</cell><cell></cell><cell></cell><cell>Mood/Anxiety</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>Anxiety</cell><cell>Disorder</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>Disorder</cell><cell></cell><cell></cell></row><row><cell cols="2">Adverse Childhood Events</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Violent Crime</cell><cell>21.0%</cell><cell>6.4%</cell><cell>3.91</cell><cell>26.1%</cell><cell>13.2%</cell><cell>2.32</cell></row><row><cell>Sexual Abuse</cell><cell>17.0%</cell><cell>7.3%</cell><cell>2.61</cell><cell>26.1%</cell><cell>9.0%</cell><cell>3.57</cell></row><row><cell>Physical Abuse</cell><cell>10.4%</cell><cell>2.7%</cell><cell>4.16</cell><cell>15.9%</cell><cell>5.0%</cell><cell>3.59</cell></row><row><cell>3 + Main</cell><cell>7.7%</cell><cell>4.6%</cell><cell>1.73</cell><cell>10.1%</cell><cell>5.3%</cell><cell>2.00</cell></row><row><cell>Caregivers</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>2 + Relocations</cell><cell>55.5%</cell><cell>43.4%</cell><cell>1.63</cell><cell>58.1%</cell><cell>49.9%</cell><cell>1.39</cell></row><row><cell>Household</cell><cell>59.3%</cell><cell>29.0%</cell><cell>3.56</cell><cell>62.5%</cell><cell>46.9%</cell><cell>1.89</cell></row><row><cell>Substance Use</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Household</cell><cell>75.0%</cell><cell>53.1%</cell><cell>2.65</cell><cell>76.6%</cell><cell>66.4%</cell><cell>1.66</cell></row><row><cell>Smoking</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>No Religious Participation*</cell><cell>11.0%</cell><cell>8.8%</cell><cell>1.28</cell><cell>11.4%</cell><cell>10.0%</cell><cell>1.16 a</cell></row><row><cell>Poor Caregiver</cell><cell>6.7%</cell><cell>3.1%</cell><cell>2.29</cell><cell>11.1%</cell><cell>3.3%</cell><cell>3.72</cell></row><row><cell>Relationship*</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Infrequent Contact with Relatives*</cell><cell>6.4%</cell><cell>3.5%</cell><cell>1.89</cell><cell>6.6%</cell><cell>5.3%</cell><cell>1.28 b</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 4</head><label>4</label><figDesc>Results of mediation models.</figDesc><table><row><cell>SE</cell><cell>p-value</cell><cell>95% CI</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head>Table 5</head><label>5</label><figDesc>Results of moderated mediation models. Models included sex, age, marital status, years of education, employment status, and income as covariates. SE = standard error, CI = con dence interval, M/AD PRS = mood and anxiety disorder polygenic risk score, SUD PRS = substance use disorder polygenic risk score.</figDesc><table><row><cell></cell><cell cols="2">African Ancestry</cell><cell></cell><cell cols="2">European Ancestry</cell><cell></cell></row><row><cell></cell><cell></cell><cell>SE</cell><cell>p-value</cell><cell></cell><cell>SE</cell><cell>p-value</cell></row><row><cell cols="6">Forward Model: Adverse Childhood Events (ACEs)Mood and Anxiety Disorders</cell><cell></cell></row><row><cell cols="2">(M/ADs)Substance Dependence (SD) 1</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>ACEs M/ADs</cell><cell>0.797</cell><cell>0.009</cell><cell>&lt; 0.001</cell><cell>0.791</cell><cell>0.009</cell><cell>&lt; 0.001</cell></row><row><cell>ACEs x M/AD PRS</cell><cell>0.016</cell><cell>0.012</cell><cell>0.181</cell><cell>0.018</cell><cell>0.011</cell><cell>0.106</cell></row><row><cell>M/ADsSDs</cell><cell>0.204</cell><cell>0.024</cell><cell>&lt; 0.001</cell><cell>0.170</cell><cell>0.019</cell><cell>&lt; 0.001</cell></row><row><cell>ACEsSDs</cell><cell>0.266</cell><cell>0.024</cell><cell>&lt; 0.001</cell><cell>0.350</cell><cell>0.020</cell><cell>&lt; 0.001</cell></row><row><cell>ACEs x SUD PRS</cell><cell>-0.145</cell><cell>0.014</cell><cell>&lt; 0.001</cell><cell>-0.209</cell><cell>0.012</cell><cell>&lt; 0.001</cell></row><row><cell>M/ADs x SUD PRS</cell><cell>-0.007</cell><cell>0.014</cell><cell>0.596</cell><cell>-0.009</cell><cell>0.011</cell><cell>0.405</cell></row><row><cell cols="7">Reverse Model: Adverse Childhood Events (ACEs)Substance Dependence (SD)Mood and Anxiety</cell></row><row><cell>Disorders (M/ADs) 2</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>ACEsSDs</cell><cell>0.509</cell><cell>0.024</cell><cell>&lt; 0.001</cell><cell>0.328</cell><cell>0.014</cell><cell>&lt; 0.001</cell></row><row><cell>ACEs x SUD PRS</cell><cell>0.013</cell><cell>0.023</cell><cell>0.552</cell><cell>-0.056</cell><cell>0.016</cell><cell>&lt; 0.001</cell></row><row><cell>SDsM/ADs</cell><cell>0.086</cell><cell>0.010</cell><cell>&lt; 0.001</cell><cell>0.184</cell><cell>0.020</cell><cell>&lt; 0.001</cell></row><row><cell>ACEsM/ADs</cell><cell>0.530</cell><cell>0.012</cell><cell>&lt; 0.001</cell><cell>0.674</cell><cell>0.013</cell><cell>&lt; 0.001</cell></row><row><cell>ACEs x M/AD PRS</cell><cell>0.005</cell><cell>0.013</cell><cell>0.676</cell><cell>-0.009</cell><cell>0.018</cell><cell>0.616</cell></row><row><cell>SDs x M/AD PRS</cell><cell>0.010</cell><cell>0.008</cell><cell>0.236</cell><cell>-0.001</cell><cell>0.016</cell><cell>0.970</cell></row><row><cell cols="7">Note: 1 Model was restricted to participants with an age of onset for rst substance dependence diagnosis</cell></row><row><cell cols="7">at or after their age of onset for a rst mood/anxiety disorder diagnosis. African ancestry, n = 1,200;</cell></row><row><cell cols="2">European ancestry, n = 1,809.</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="7">2 Model was restricted to participants with an age of onset of a rst mood/anxiety disorder at or later</cell></row><row><cell cols="7">than the age of onset for a rst substance dependence diagnosis. African ancestry, n = 1,164;</cell></row><row><cell cols="2">European ancestry, n = 1,539.</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div><p>Acknowledgment: This work was supported by the <rs type="funder">Veterans Integrated Service Network 4 Mental Illness Research, Education and Clinical Center</rs> and by grants <rs type="grantNumber">AA028292</rs> to RLK and <rs type="grantNumber">IK2 CX002336</rs> to EEH.</p></div>
			</div>
			<listOrg type="funding">
				<org type="funding" xml:id="_RWgYsDF">
					<idno type="grant-number">AA028292</idno>
				</org>
				<org type="funding" xml:id="_4G7kBfz">
					<idno type="grant-number">IK2 CX002336</idno>
				</org>
			</listOrg>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusions</head><p>Although we found support for both the self-medication hypothesis of SD and substance-induced M/ADs, there was greater support for the former. In fact, 90% of the risk of M/ADs was explained by the direct effect of ACEs. Interestingly, rather than heightening the effect of ACEs on SDs, among individuals with higher SUD polygenic risk, ACEs had less of an effect on SD risk, suggesting that the effect of genetic liability exceeded the impact of the environmental risk factor. In contrast, among individuals at lower genetic risk for SUDs, ACEs appear more likely to precipitate the development of an SD. PRS for M/ADs, however, did not moderate the effect of ACEs on M/ADs, indicating that the risk of developing these disorders is elevated by exposure to these childhood events, regardless of genetic liability. These ndings argue for universal screening for ACEs and trauma-informed interventions in schools and communities to reduce the substantial impact of ACEs on risk for both M/ADs and SDs. Declarations Disclosure: Dr. Kranzler is a member of advisory boards for Dicerna Pharmaceuticals, Sophrosyne Pharmaceuticals, Enthion Pharmaceuticals, and Clearmind Medicine; a consultant to Sobrera Pharmaceuticals; the recipient of research funding and medication supplies for an investigator-initiated study from Alkermes; and a member of the American Society of Clinical Psychopharmacology's Alcohol Clinical Trials Initiative, which was supported in the last three years by Alkermes, Dicerna, Ethypharm, Lundbeck, Mitsubishi, Otsuka, and Pear Therapeutics. Drs. Kranzler and Gelernter hold U.S. patent 10,900,082 titled: "Genotype-guided dosing of opioid agonists," issued 26 January 2021. The other authors have no disclosures to make.  </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Supplementary Files</head><p>This is a list of supplementary les associated with this preprint. Click to download.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>SupplementaryFigures.docx</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>SupplementaryTables.xlsx</head></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Childhood maltreatment, depression, and suicidal ideation: critical importance of parental and peer emotional abuse during developmental sensitive periods in males and females</title>
		<author>
			<persName><forename type="first">A</forename><surname>Khan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Front. Psychiatry</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">42</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">The association between ve forms of child maltreatment and depressive and anxiety disorders: a systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Gardner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Thomas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">E</forename><surname>Erskine</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Child Abuse Negl</title>
		<imprint>
			<biblScope unit="volume">96</biblScope>
			<biblScope unit="page">104082</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Childhood trauma and its relation to chronic depression in adulthood</title>
		<author>
			<persName><forename type="first">A</forename><surname>Negele</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kaufhold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Kallenbach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Leuzinger-Bohleber</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Depress. Res. Treat</title>
		<imprint>
			<biblScope unit="page">650804</biblScope>
			<date type="published" when="2015">2015. 2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Childhood trauma and adult interpersonal relationship problems in patients with depression and anxiety disorders</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Huh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">Y</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Chae</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann. Gen. Psychiatry</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page">26</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">The biological effects of childhood trauma. Child and Adolesc</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>De Bellis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Zisk</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychiatr. Clin. N. Am</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="185" to="222" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Childhood trauma, posttraumatic stress disorder, and alcohol dependence</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">T</forename><surname>Brady</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Back</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Alcohol Res. Curr. Rev</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="408" to="413" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Childhood trauma exposure and alcohol dependence severity in adulthood: mediation by emotional abuse severity and neuroticism</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Schwandt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Heilig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">W</forename><surname>Hommer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">T</forename><surname>George</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">A</forename><surname>Ramchandani</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Alcohol. Clin. Exp. Res</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="984" to="992" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">A rapid systematic review on the association between childhood and sexual abuse and illicit drug use among males</title>
		<author>
			<persName><forename type="first">S</forename><surname>Butt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Chou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Browne</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Child Abuse Rev</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="6" to="38" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Re-examining the link between childhood maltreatment and substance use disorder: a prospective, genetically informative study</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Capusan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Psychiatry</title>
		<imprint>
			<biblScope unit="page" from="3201" to="3209" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Patterns of adverse childhood experiences and substance use among young adults: a latent class analysis</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Shin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Mcdonald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Conley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Addict. Behav</title>
		<imprint>
			<biblScope unit="volume">78</biblScope>
			<biblScope unit="page" from="187" to="192" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Risk for substance use disorders in young adulthood: associations with developmental experiences of homelessness, foster care, and adverse childhood experiences</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">B</forename><surname>Moss</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Compr. Psychiatry</title>
		<imprint>
			<biblScope unit="volume">100</biblScope>
			<biblScope unit="page">152175</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Adverse childhood experience patterns, major depressive disorder, and substance use disorder in older adults</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>Chartier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">L</forename><surname>Wike</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Mcdonald</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Aging Ment. Health</title>
		<imprint>
			<biblScope unit="page" from="484" to="491" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Unpacking the impact of adverse childhood experiences on adult mental health</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Merrick</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Child Abuse Negl</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="page" from="10" to="19" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Adverse childhood events as risk factors for substance dependence: partial mediation by mood and anxiety disorders</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">R</forename><surname>Douglas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Addict. Behav</title>
		<imprint>
			<biblScope unit="page" from="7" to="13" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Depressive symptoms prospectively increase risk for new onset cigarette and ENDS dependence symptoms</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Thomas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>Pasch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">N</forename><surname>Marti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Loukas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Addict. Behav</title>
		<imprint>
			<biblScope unit="volume">148</biblScope>
			<biblScope unit="page">107870</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Bipolar disorder and cannabis use: a bidirectional two-sample mendelian randomization study</title>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">H</forename><surname>Jefsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Speed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Speed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Ostergaard</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Addict. Biol</title>
		<imprint>
			<biblScope unit="page">13030</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Posttraumatic stress disorder, drinking to cope, and harmful alcohol use: a multivariate meta-analysis of the self-medication hypothesis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Luciano</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Psychopathol. Clin. Sci</title>
		<imprint>
			<biblScope unit="volume">131</biblScope>
			<biblScope unit="page" from="447" to="456" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Alcohol dependence and mood disorders</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">B</forename><surname>Raimo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Schuckit</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Addict. Behav</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="933" to="946" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Polygenic scores for major depressive disorder and risk of alcohol dependence</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Andersen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JAMA Psychiatry</title>
		<imprint>
			<biblScope unit="volume">74</biblScope>
			<biblScope unit="page" from="1153" to="1160" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Major depression and comorbid substance use disorders</title>
		<author>
			<persName><forename type="first">L</forename><surname>Davis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Uezato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Newell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Frazier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr. Opin. Psychiatry</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="14" to="18" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Comorbidity between major depression and alcohol use disorder from adolescence to adulthood</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">N</forename><surname>Brire</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Rohde</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Seeley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Klein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Lewinsohn</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Compr. Psychiatry</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="526" to="533" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Alcohol use disorder and depressive disorders</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Mchugh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Weiss</surname></persName>
		</author>
		<idno>40.1.01</idno>
	</analytic>
	<monogr>
		<title level="j">Alcohol Res. Curr. Rev</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Determination shared genetic etiology and possible causal relations between tobacco smoking and depression</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Yao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychol. Med</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="1870" to="1879" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Evidence causal effects of lifetime smoking on risk for depression and schizophrenia: a mendelian randomization study</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Wootton</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychol. Med</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="page" from="2435" to="2443" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Mood and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid-use disorder: longitudinal evidence from the national epidemiologic study on alcohol and related conditions</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Martins</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychol. Med</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="1261" to="1272" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Depression effects on long-term prescription opioid use, abuse, and addiction</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Sullivan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">The Clinical Journal of Pain</title>
		<imprint>
			<biblScope unit="page" from="878" to="884" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Prescription opioid use and risk for major depressive disorder: a multivariable mendelian randomization analysis</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Rosoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">D</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">W</forename><surname>Lohoff</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JAMA Psychiatry</title>
		<imprint>
			<biblScope unit="volume">78</biblScope>
			<biblScope unit="page" from="151" to="160" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">The bidirectional relationships between alcohol, cannabis, co-occurring alcohol and cannabis use disorders with major depressive disorder: results from a national sample</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">R</forename><surname>Pacek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Martins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Crum</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Affect. Disord</title>
		<imprint>
			<biblScope unit="volume">148</biblScope>
			<biblScope unit="page" from="188" to="195" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Alcohol induced depression: clinical, biological and genetic features</title>
		<author>
			<persName><forename type="first">A</forename><surname>Farr</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Clin. Med</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">2668</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Depression among cocaine abusers in treatment: relation to cocaine and alcohol use and treatment outcome</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Brown</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Psychiatry</title>
		<imprint>
			<biblScope unit="volume">155</biblScope>
			<biblScope unit="page" from="220" to="225" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Psychiatric comorbidity in treatment-seeking cocaine abusers</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Halikas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Crosby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">L</forename><surname>Pearson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Nugent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Carlson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Addict</title>
		<imprint>
			<biblScope unit="page" from="25" to="35" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Translating genetic research into preventive intervention: the baseline target moderated mediator design</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">W</forename><surname>Howe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R H</forename><surname>Beach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">H</forename><surname>Brody</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Wyman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Front. Psychol</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">1911</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Polygenic risk scores: from research tools to clinical instruments</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Lewis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Vassos</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genome Med</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page">44</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Applying a genetic risk score for prostate cancer to men with lower urinary tract symptoms in primary care to predict prostate cancer diagnosis: a cohort study in the UK biobank</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">D</forename><surname>Green</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br. J. Cancer</title>
		<imprint>
			<biblScope unit="volume">127</biblScope>
			<biblScope unit="page" from="1534" to="1537" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Polygenic risk score: clinically useful tool for prediction of cardiovascular disease and bene t from lipid-lowering therapy? Cardiovasc</title>
		<author>
			<persName><forename type="first">N</forename><surname>Arnold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Koenig</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Drugs Ther</title>
		<imprint>
			<biblScope unit="page" from="627" to="635" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Meta-analysis of genome-wide association studies of anxiety disorders</title>
		<author>
			<persName><forename type="first">T</forename><surname>Otowa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Psychiatry</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="1391" to="1399" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">A major role for common genetic variation in anxiety disorders</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Purves</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Psychiatry</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="3292" to="3303" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Reproducible genetic risk loci for anxiety: results from 200,000 participants in the Million Veteran Program</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">F</forename><surname>Levey</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Psychiatry</title>
		<imprint>
			<biblScope unit="volume">177</biblScope>
			<biblScope unit="page" from="223" to="232" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Depression pathophysiology, risk prediction of recurrence and comorbid psychiatric disorders using genome-wide analyses</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">D</forename><surname>Als</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Med</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="1832" to="1844" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology</title>
		<author>
			<persName><forename type="first">N</forename><surname>Mullins</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="page" from="817" to="829" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Genome-wide association analyses of post-traumatic stress disorder and its symptom subdomains in the Million Veteran Program</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Stein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="page" from="174" to="184" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Revealing the complex genetic architecture of obsessive-compulsive disorder using meta-analysis</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">D</forename><surname>Arnold</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Psychiatry</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="1181" to="1188" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Bi-ancestral depression GWAS in the Million Veteran Program and meta-analysis in &gt;1.2 million individuals highlight new therapeutic directions</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">F</forename><surname>Levey</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Neurosci</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="954" to="963" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Genome-wide association studies of schizophrenia and bipolar disorder in a diverse cohort of US veterans</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">B</forename><surname>Bigdeli</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Schizophr. Bull</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="517" to="529" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Multi-ancestry study of the genetics of problematic alcohol use in &gt;1 million individuals</title>
		<author>
			<persName><forename type="first">H</forename><surname>Zhou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint/>
	</monogr>
	<note>in press</note>
</biblStruct>

<biblStruct xml:id="b45">
	<monogr>
		<title level="m" type="main">Multi-ancestry meta-analysis of tobacco use disorder prioritizes novel candidate risk genes and reveals associations with numerous health outcomes. medRxiv [Preprint]</title>
		<author>
			<persName><forename type="first">S</forename><surname>Toikumo</surname></persName>
		</author>
		<idno>2023.03.27.23287713</idno>
		<imprint>
			<date type="published" when="2023-09-18">2023 Sep 18</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Cross-ancestry meta-analysis of opioid use disorder uncovers novel loci with predominant effects in brain regions associated with addiction</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Kember</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Neurosci</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="1279" to="1287" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Multi-ancestry genome-wide association study of cannabis use disorder yields insight into disease biology and public health implications</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">F</forename><surname>Levey</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint/>
	</monogr>
	<note>in press</note>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">A large-scale genome-wide association study meta-analysis of cannabis Use Disorder</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">C</forename><surname>Johnson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet Psychiatry</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="1032" to="1045" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Phenome-wide association analysis of substance use disorders in a deeply phenotyped sample</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Kember</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biol. Psychiatry</title>
		<imprint>
			<biblScope unit="page" from="536" to="545" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<monogr>
		<title level="m" type="main">Diagnostic and statistical manual of mental disorders (DSM-IV)</title>
		<imprint>
			<date type="published" when="1994">1994</date>
			<publisher>American Psychiatric Association</publisher>
			<pubPlace>Washington, DC</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Diagnostic reliability of the Semi-Structured Assessment for Drug Dependence and Alcoholism (SSADDA)</title>
		<author>
			<persName><forename type="first">A</forename><surname>Pierucci-Lagha</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Drug Alcohol Depend</title>
		<imprint>
			<biblScope unit="volume">80</biblScope>
			<biblScope unit="page" from="303" to="312" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Reliability of DSM-IV diagnostic criteria using the Semi-Structured Assessment for Drug Dependence and Alcoholism (SSADDA)</title>
		<author>
			<persName><forename type="first">A</forename><surname>Pierucci-Lagha</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Drug Alcohol Depend</title>
		<imprint>
			<biblScope unit="volume">91</biblScope>
			<biblScope unit="page" from="85" to="90" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Genomic structural equation modelling provides insights into the multivariate genetic architecture of complex traits</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Grotzinger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Hum. Behav</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="513" to="525" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Multi-trait analysis of genome-wide association summary statistics using MTAG</title>
		<author>
			<persName><forename type="first">P</forename><surname>Turley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="page" from="229" to="237" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<monogr>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">K</forename><surname>Muthn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">O</forename><surname>Muthn</surname></persName>
		</author>
		<title level="m">Mplus user&apos;s guide</title>
		<meeting><address><addrLine>Los Angeles, CA</addrLine></address></meeting>
		<imprint>
			<date type="published" when="1998">1998-2017</date>
			<biblScope unit="volume">8</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">The self-medication hypothesis of substance use disorders: a reconsideration and recent applications</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Khantzian</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Harv. Rev. Psychiatry</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="231" to="244" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">A developmental approach to complex PTSD: childhood and adult cumulative trauma as predictors of symptom complexity</title>
		<author>
			<persName><forename type="first">M</forename><surname>Cloitre</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Traumatic Stress</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="399" to="408" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Emotion regulation mediates the relationship between ACEs and physical and mental health</title>
		<author>
			<persName><forename type="first">M</forename><surname>Cloitre</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychol. Trauma</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="82" to="89" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">Comorbidity between substance use disorder and psychiatric conditions</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Schuckit</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Addiction</title>
		<imprint>
			<biblScope unit="volume">101</biblScope>
			<biblScope unit="page" from="76" to="88" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">Alcohol dependence and mood disorders</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">B</forename><surname>Raimo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Schuckit</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Addictive Behav</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="933" to="946" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">Methods to assess adverse childhood experiences of children and families: toward approaches to promote child well-being in policy and practice</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Bethell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acad. Pediatr</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="51" to="69" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">Making schools trauma informed: using the ACE study and implementation science to screen for trauma</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Pataky</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Social Work Mental Health</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="639" to="661" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">Reducing adverse childhood experiences (ACE) by building community capacity: a summary of Washington family policy council research ndings</title>
		<author>
			<persName><forename type="first">J</forename><surname>Hall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Porter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Longhi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Necker-Green</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Dreyfus</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Prev. Interv. Community</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="325" to="334" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main">Community-wide resilience mitigates adverse childhood experiences on adult and youth health, school/work, and problem behaviors</title>
		<author>
			<persName><forename type="first">D</forename><surname>Longhi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Fromm Reed</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. Psychol</title>
		<imprint>
			<biblScope unit="volume">76</biblScope>
			<biblScope unit="page" from="216" to="229" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main">Screening adults with substance use disorder for adverse childhood experiences</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">E</forename><surname>Chandler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Kalmakis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Murtha</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Addictions Nurs</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page">172</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main">Depression and its association with adverse childhood experiences in people with substance use disorders and comorbid medical illness recruited during medical hospitalization</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">L</forename><surname>Philogene-Khalid</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Addict. Behav</title>
		<imprint>
			<biblScope unit="volume">110</biblScope>
			<biblScope unit="page">106489</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main">Adverse childhood experience effects on opioid use initiation, injection drug use, and overdose among persons with opioid use disorder</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Stein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Drug Alcohol Depend</title>
		<imprint>
			<biblScope unit="volume">179</biblScope>
			<biblScope unit="page" from="325" to="329" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title level="a" type="main">Evaluation of an intervention promoting emotion regulation skills for adults with persisting distress due to adverse childhood experiences</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">D</forename><surname>Cameron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Carroll</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Hamilton</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Child Abuse Negl</title>
		<imprint>
			<biblScope unit="volume">79</biblScope>
			<biblScope unit="page" from="423" to="433" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main">Emotion regulation promotes persistence in a residential substance abuse treatment</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Hopwood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Schade</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Matusiewicz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">B</forename><surname>Daughters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">W</forename><surname>Lejuez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Subst. Use Misuse</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="page" from="251" to="256" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b70">
	<analytic>
		<title level="a" type="main">Wellness, emotion regulation, and relapse during substance use disorder treatment</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">B</forename><surname>Clarke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">F</forename><surname>Lewis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Myers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Henson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Hill</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Counsel. Dev</title>
		<imprint>
			<biblScope unit="volume">98</biblScope>
			<biblScope unit="page" from="17" to="28" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b71">
	<analytic>
		<title level="a" type="main">Diathesis-stress models of psychopathology: A quantitative genetic perspective</title>
		<author>
			<persName><forename type="first">R</forename><surname>Rende</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Plomin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Appl. Preventive Psychol</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="177" to="182" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
